This inventor holds 1 USPTO granted patent. Top assignee: Qjv, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Paul R Reising: Innovator in Nutraceuticals
Introduction
Paul R Reising is a notable inventor based in Evansville, IN (US). He has made significant contributions to the field of nutraceuticals, particularly in the area of diabetes management. His innovative work focuses on enhancing the nutritional value of rice bran and its application in reducing insulin resistance.
Latest Patents
Reising holds a patent for a "Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same." This patent outlines a method for utilizing hydrophilic and lipophilic rice bran fractions to reduce insulin resistance in animals, especially humans suffering from pre-diabetes and Type 2 diabetes. The patent details various mixtures containing elevated levels of nutraceutical compounds, including gamma-oryzanol, inositol, ferulic acid, tocotrienols, and phytosterols. It also provides a comprehensive approach to managing therapy for individuals with symptoms of Metabolic Syndrome.
Career Highlights
Throughout his career, Reising has focused on developing innovative solutions to health challenges. His work has been instrumental in advancing the understanding of how specific compounds in rice bran can positively impact metabolic health. He is associated with QJV, LLC, where he continues to explore the potential of nutraceuticals in improving health outcomes.
Collaborations
Reising collaborates with Glenn H Sullivan, contributing to the advancement of research in the field of nutraceuticals. Their partnership emphasizes the importance of teamwork in driving innovation and developing effective health solutions.
Conclusion
Paul R Reising's contributions to the field of nutraceuticals highlight the potential of rice bran in managing insulin resistance and improving metabolic health. His innovative approach and dedication to research continue to pave the way for advancements in diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile